Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Nsc Stock In Focus Buying Pressure Builds 20260403 1 Abts Stock Analysis Abits Group Inc Ordinary Shares Up 5.67 At 1.49 Price Level 20260403 Is Pmgc Holdings Elab Stock A Growth Play Price At 4.98 Up 3.97 20260413 Will Carriage Csv Stock Hit Record Highs Price At 45.73 Down 1.61 20260406 Is Fortinet Ftnt Stock Lagging The Market Price At 84.40 Up 0.81 20260408 USAC USA Compression Partners LP posts 84 Q4 2025 EPS miss and 5 YoY revenue growth shares fall 059 Metallus MTUS Balance Sheet Review Q4 2025 EPS Misses Estimates What you need to know before buying Kaixin Holdings KXIN Underperforming 20260507 PCOR Procore Technologies Inc rises 241 percent following narrow Q4 2025 EPS beat that lifts investor confidence Market Indexes Market Downs as Investors Digest Why Cameco CCJ might be the best kept secret in the market 145 20260511 ESAB Corporation ESAB posts 37 YoY Q4 2025 revenue gain falls 18 after narrow EPS miss Is Sound SPMC Stock a Good Dividend Stock 051 20260420 NorthWestern NWE Stock Market Structure Shift Investor Interest 20260420 US Consumer Sentiment and Macroeconomic Risk Assessment Amid Middle East Geopolitical Volatility Duke Energy Corporation DUK Valuation Disparity Persists Amid LongTerm Grid Investment Plans At 12860 Share Price AREB AmRebel shares plunge 21 after Q2 loss widens to 534 per share investor confidence shaken LENZ Therapeutics LENZ Stock Market Influencing Factors LENZ Therapeutics posts 171 EPS miss on wider quarterly loss CBC Central Banc delivers Q1 2026 EPS ahead of forecasts shares edge higher on positive investor sentiment Supreme Court Goes Digital Hearings Move Online Fuel Conservation Measures Take Center Stage Gates GTES Q1 2026 Earnings Surprise EPS 035 Up Significant Subaru Delays InHouse EV Production Plans Beyond 2028 Reassessing Strategy Stepan Company SCL Q1 2026 Earnings 045 EPS Surges Past 044 Estimates Is NatWest NWG Still a Buy After 147 Rally 20260518 Stoke Therapeutics STOK Fell 349 Is a Recovery Ahead 20260518 Tianci Intl CIIT Stock Slides 317 Support at 116 20260515 Vuzix Corporation VUZI Q1 2026 Beat Revenue NA EPS Exceeds by Significant Shutterstock SSTK Gains 45 Testing Resistance After Bounce from Support Retail Investors Gain Direct Access to SpaceX IPO Through Major Brokerage Platforms Enhabit EHAB Q4 2025 Results Fall Short EPS 014 Revenue NA AI Boom Reshapes Global Market Rankings as South Korea Taiwan Surge Past Western Peers Yes Bank PNB Bandhan Bank Draw Analyst Attention as ShortTerm Options Under 200 Subramanian Swamy Calls for Ban on Cement Imports from Pakistan Citing Security Risks Safepoints Potential 116 Billion Valuation Highlights Growing Interest in Florida Insurer IPO Live Music Spending Shifts Consumers Prioritize Intentionally Amid Inflation Oxford Industries OXM Q1 2026 Earnings Surprise Loss Meets Optimistic Market Sentiment MediaAlpha MAX Q1 2026 Earnings EPS Misses Estimates Despite Modest Stock Gain AEHR Q1 2026 Earnings Narrowerthanexpected loss drives positive stock reaction RYAN Q1 2026 Earnings EPS Surpasses Estimates Amid Solid Underwriting Trends LUMN Q1 2026 Earnings Significant EPS Miss as Company Faces Ongoing Challenges Neuronetics STIM Shows Modest Rebound Support Levels Under Scrutiny PriceSmart Inc PSMT Edges Higher as Stock Holds Above Key Support Level STRK Preferred Shares Edge Higher Consolidating Near Resistance Protara Therapeutics TARA posts widerthanexpected Q4 2025 loss shares dip slightly in todays trading session Occidental Petroleum OXY Q4 Earnings Miss Overshadowed by Geopolitical Tailwinds and Berkshire Backing Driving 215 PostReport Rally What LEIFRAS LFS management said that matters most LFS Q3 Earnings Financial Metrics Remain Unavailable IHRT iHeartMedia posts far wider than projected Q4 2025 loss even as its shares rise 211 percent in todays trading EOG Resources Inc EOG Q1 2026 Earnings Preview Robust Growth Trajectory and High Beat Probability Amid Tight Energy Markets OVID Ovid Therapeutics swings to profit with 1181 revenue jump defying biotech sector headwinds in Q4 2025 Why Western WIW could deliver where others fall short Risk Aversion 20260508